Gt biopharma ceo, tony cataldo to present at sir anthony ritossa's global family office investment summit

Beverly hills, calif, june 24, 2021 /prnewswire/ -- gt biopharma, inc. ("gt biopharma" or the "company") (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager (trike™) protein biologic technology platform, today announced that gt biopharma ceo, tony cataldo will be presenting as a vip speaker at the upcoming sir anthony ritossa's global family office investment summit in monaco from june 30 to july 2, 2021. the sir anthony ritossa's global family office investment summit in monaco is one of a series of international summits held annually as a platform for exceptional networking between family offices and thought leaders from all over the world.
GTBP Ratings Summary
GTBP Quant Ranking